Primordial Genetics today announced the first closing of its Series A-2 financing round, including a group of 5 private investors.
The company will use the capital it has raised to support additional R&D activities to develop superior microbial strains for production of high-value proteins including human therapeutic proteins and industrial enzymes.
Related Articles
-
-
Primordial Genetics Inc launches R&D operations
Primordial Genetics Inc has launched its laboratory operations at the JLABS biotechnology incubator on July 19, 2013. The company...
-
-
-
James E. Levine joins Primordial Genetics’ Board of Directors
James “Jamie” Levine has joined Primordial Genetics’ Board of Directors, bringing deep executive experience in industrial biotechnology and finance...
-
-
-
Go Beyond Investing conducts due diligence on Primordial Genetics
Go Beyond Investing (https://go-beyond.biz/) is a FinTech company transforming angel investing into a new scalable asset class for small...
0 Comments